Michael Sidler

Michael Sidler is a board member at Versantis. Michael has also been a part of companies such as Sanity Group, Araris Biotech AG, Mushlabs, ImmunOs Therapeutics AG, aktiia, SECA - Swiss Private Equity & Corporate Finance Association, and Memo Therapeutics AG. Sidler has also been a part of Redalpine Venture Partners.

Michael Sidler has a background in Executive Programs from Singularity University and a PhD in Plant Molecular Biology from the University of Zurich.